What is Genentech’s competitive advantage, if any?
What impact will changes in health care and biogenerics regulation have on Genentech? Why?
How would you describe Genentech’s competitive position?
What impact will the Roche buyout have on Genentech? Will it be possible for Roche to own Genentech without destroying its ability to innovate?
What is the major dilemma that Mr. Scheller faces in the case? What should he do?
